Bio-Techne Corporation TECH 深 滬
等待開盤 04-02 09:30:00 美东时间
53.48
+1.220
+2.33%
華盛通- 最 高54.10
- 今 開52.29
- 成交量 245.78万股
- 最 低 52.29
- 昨 收 52.26
- 總市值 83.67亿
- 52周最高 72.08
- 市盈率 靜 116.44
- 換手率 1.57%
- 52周最低 45.69
- 委 比 75.35%
- 總股本 1.56亿
- 歷史最高 134.5225
- 量 比 1.33
- 振 幅 3.46%
- 歷史最低 11.6925
- 每 手 1
- 風險率 5.81%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Bio-Techne Expands COMET Solution Portfolio With Addition Of New SPYRE Focus Panels And SPYRE Amplification Kits
New SPYRE™ Focus Panels (Stroma and Vessel) broaden modular panel options, enabling deeper targeted insights in spatial biology workflows. SPYRE™ Amplification Kits leverage sequential
03-25 18:34
Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite
New SPYRE™ Focus Panels (Stroma and Vessel) broaden modular panel options, enabling deeper targeted insights in spatial biology workflows. SPYRE™ Amplification Kits leverage sequential and ...
03-25 18:30
Stocks most neglected by hedge funds by sector
BofA Securities tallied up the stocks in each sector where hedge funds are most broadly underweight. Here are the stocks: Sector Company (Ticker) Rel Wt % of Funds Owning Communication Services News ...
03-18 20:16
Bio-Techne to Present at TD Cowen Annual Health Care Conference and Leerink Partners Global Healthcare Conference
Bio-Techne to Present at TD Cowen Annual Health Care Conference and Leerink Partners Global Healthcare Conference Bio-Techne Corporation will present at the TD Cowen 46th Annual Health Care Conference on March 3, 2026 at 11:10 AM EST, and at the Leerink Partners Global Healthcare Conference on March
02-24 20:00
Bio-Techne Director Amy E. Herr Disposes of Common Shares
Bio-Techne Director Amy E. Herr Disposes of Common Shares Amy E. Herr, a director of Bio-Techne Corporation, reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using genera
02-20 05:58
Bio-Techne Names Steve Crouse President of Diagnostics and Spatial Biology Segment
Bio-Techne Names Steve Crouse President of Diagnostics and Spatial Biology Segment Bio-Techne Corporation announced that Dr. Matt McManus will step down as President of the Diagnostics and Spatial Biology Segment effective March 1, 2026. Steve Crouse, currently Senior Vice President of the Analytica
02-11 22:04
美股大行评级 | 遭多家大行下调目标价！亚马逊、Affirm、Roblox、汤森路透、Doximity、OneMain、Atlassian、Peloton等等
今日重点评级关注：HC Wainwright & Co.：维持NovaBridge Biosciences"买入"评级，目标价从7美元升至9美元；Truist Securities：维持Reddit"买入"评级，目标价从270美元升至275美元
02-09 14:37
美股大行评级 | 谷歌绩后获14家大行上调目标价；Arm、高通、波士顿科学、艾可菲、Snap、优步遭多家大行下调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Wave Life Sciences Ltd."超配"评级，目标价从34美元升至41美元；Piper Sandler：维持Replimune Group"超配"评级，目标价从13美元升至14美元
02-06 16:52
财报速睇 | Bio-Techne Corporation 2025财年Q4营收2.96亿美元，同比下降0.4%；归母净利润0.38亿美元，同比增长8.9%
华盛资讯2月6日讯，Bio-Techne Corporation公布2025财年Q4业绩，公司Q4营收2.96亿美元，同比下降0.4%，归母净利润0.38亿美元，同比增长8.9%。
02-06 02:48
UBS Maintains Buy on Bio-Techne, Raises Price Target to $79
UBS analyst Dan Leonard maintains Bio-Techne (NASDAQ:TECH) with a Buy and raises the price target from $70 to $79.
02-05 23:25
